2 Healthcare Stock Winners and 3 Losers After Earnings Are Digested

Medicines Co. (NASDAQ:MDCO) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.21 in the quarter versus EPS of $0.14 in the year-earlier quarter. Revenue Rose 23.06% to $155.8 million from the year-earlier quarter.

Medicines Co. reported adjusted EPS loss of $0.21 per share. By that measure, the company beat the mean analyst estimate of $-0.26. It beat the average revenue estimate of $152.63 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

MDCO

VCA Antech Inc. (NASDAQ:WOOF) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 17.65% to $0.40 in the quarter versus EPS of $0.34 in the year-earlier quarter. Revenue Rose 7.12% to $438.61 million from the year-earlier quarter.

VCA Antech Inc. reported adjusted EPS income of $0.40 per share. By that measure, the company beat the mean analyst estimate of $0.36. It missed the average revenue estimate of $447.21 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

WOOF

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.31 in the quarter versus EPS of $-0.21 in the year-earlier quarter. Revenue Rose 9.64% to $127.9 million from the year-earlier quarter.

BioMarin Pharmaceutical Inc. reported adjusted EPS loss of $0.31 per share. By that measure, the company missed the mean analyst estimate of $-0.29. It missed the average revenue estimate of $131.44 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

BMRN

Bristol-Myers Squibb Company (NYSE:BMY) delivered a profit and met Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 35.94% to $0.41 in the quarter versus EPS of $0.64 in the year-earlier quarter. Revenue Decreased 27.04% to $3.83 billion from the year-earlier quarter.

Bristol-Myers Squibb Company reported adjusted EPS income of $0.41 per share. By that measure, the company met the mean analyst estimate of $0.41. It missed the average revenue estimate of $3.88 billion.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

BMY

Greatbatch, Inc. (NYSE:GB) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 18.92% to $0.44 in the quarter versus EPS of $0.37 in the year-earlier quarter. Revenue Decreased 6.81% to $148.26 million from the year-earlier quarter.

Greatbatch, Inc. reported adjusted EPS income of $0.44 per share. By that measure, the company beat the mean analyst estimate of $0.42. It missed the average revenue estimate of $160.14 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

GB

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.